Discussion on the Treatment Methods and Value of the No-Reflow Phenomenon During Percutaneous Coronary Intervention

W Ma, L Wei, Y You, H Zhao, P Wang… - Cardiovascular …, 2023 - ojs.bbwpublisher.com
Objective: To explore the treatment methods and value of the no-reflow phenomenon during
percutaneous coronary intervention (PCI). Methods: 180 patients with acute myocardial …

Progression of no-reflow prevention and treatment in percutaneous coronary intervention

X LI, Y KE - Chinese Journal of Clinical Pharmacology …, 2011 - manu41.magtech.com.cn
As percutaneous coronary intervention is widely used in clinic, more and more acute ST-
segment elevation myocardial infarction patients undergo direct PCI. However, no-reflow …

Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention

S Abdi, O Rafizadeh, M Peighambari… - Research in …, 2015 - journals.lww.com
Background: The no-reflow phenomenon is an uncommon and critical occurrence which
myocardial reperfusion does not restore to its optimal level. Several predisposing factors of …

Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct …

H Li, DG Fu, FY Liu, H Zhou… - Experimental and …, 2018 - spandidos-publications.com
This study determined the related factors of no-reflow phenomenon in patients with acute ST-
segment elevation myocardial infarction (STEMI) after direct percutaneous coronary …

The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality

EH Choo, PJ Kim, K Chang, Y Ahn, DS Jeon… - Coronary artery …, 2014 - journals.lww.com
Background The no-reflow phenomenon is a potential complication of primary percutaneous
coronary intervention (PCI). Predictors of the no-reflow phenomenon and the impact on long …

ASSA14-12-18 Effects of intracoronary diltiazem and sodium nitroprusside on no-reflow phenomenon after percutaneous coronary intervention in patients with acute …

C Zhang-Qiang, H Lang, Y Min, W Hong, Y Qiu-lin… - 2015 - heart.bmj.com
Objective To evaluate the efficacy and safety of the selective intracoronary injection of
diltiazem and sodium nitroprusside on the no-reflow after percutaneous coronary …

Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: Contributing factors and long-term prognostic impact

YL Han, J Deng, QM Jing, SL Wang… - Zhonghua xin xue …, 2006 - europepmc.org
Objective To elucidate the relative factors and prognostic impact for angiographic no-reflow
phenomenon during primary percutaneous coronary intervention (PCI) in patients with acute …

[HTML][HTML] Correlates of the “no-reflow” or “slow-flow” phenomenon in patients undergoing primary percutaneous coronary intervention

M Alidoosti, R Lotfi, M Lotfi-Tokaldany… - The Journal of Tehran …, 2018 - ncbi.nlm.nih.gov
Background: Despite recent advances in interventional equipment and techniques, the
angiographic no-reflow phenomenon occurs in a considerable number of patients …

Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention

T Ashraf, MN Khan, SM Afaque, KF Aamir… - International journal of …, 2019 - Elsevier
Objectives In the present study, we analysed the incidence of no-reflow phenomenon, its
clinical and procedural predictors, and associated in-hospital outcomes for the patients …

No-reflow phoenomenon by intracoronary thrombus in acute myocardial infarction

SY Lim - Chonnam Medical Journal, 2016 - synapse.koreamed.org
Recently, percutaneous coronary intervention has been the treatment of choice in most
acute myocardial infarction cases. Although the results of percutaneous coronary …